Cited by 319Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementGlycogen Storage Diseases and Myoclonus

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Open access

Hunter, Roger W., Hughey, Curtis C., Lantier, Louise, Sundelin, Elias I., Peggie, Mark, Zeqiraj, Elton, Sicheri, Frank, Jessen, Niels, Wasserman, David H., Sakamoto, Kei·2018·Nature Medicine

DOI 10.1038/s41591-018-0159-7PMC PMC6207338

Open this paper in CoChat — free account Open PDF

Abstract

Metformin is a first-line drug for the treatment of individuals with type 2 diabetes, yet its precise mechanism of action remains unclear. Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP). This suppression is thought to be mediated through inhibition of mitochondrial respiratory complex I, and thus elevation of 5′-adenosine monophosphate (AMP) levels and the activation of AMP-activated protein kinase (AMPK), though this proposition has been challenged given results in mice lacking hepatic AMPK. Here we report that the AMP-inhibited enzyme fructose-1,6-bisphosphatase-1 (FBP1), a rate-controlling enzyme in gluconeogenesis, functions as a major contributor to the therapeutic action of metformin. We identified a point mutation in FBP1 that renders it insensitive to AMP while sparing regulation by fructose-2,6-bisphosphate (F-2,6-P2), and knock-in (KI) of this mutant in mice significantly reduces their response to metformin treatment. We observe this during a metformin tolerance test and in a metformin-euglycemic clamp that we have developed. The antihyperglycemic effect of metformin in high-fat diet–fed diabetic FBP1-KI mice was also significantly blunted compared to wild-type controls. Collectively, we show a new mechanism of action for metformin and provide further evidence that molecular targeting of FBP1 can have antihyperglycemic effects. The antidiabetic action of metformin raises heptocyte intracellular AMP levels, causing allosteric inhibition of fructose-1,6-bisphosphatase and thus reductions in gluconeogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0159-7

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Methods of Enzymatic Analysis
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Anorexigenic and Orexigenic Hormone Modulation of Mammalian Target of Rapamycin Complex 1 Activity and the Regulation of Hypothalamic Agouti-Related Protein mRNA Expression
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
[1] Citrate synthase
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399

Show all 86 references

Research works printed but not linked: 1

Noll, F. Methods of Enzymatic Analysis 3rd edn, Vol. 6 (ed. Bergmeyer, H. U.) 582–588 (Verlag Chemie, Weinheim, Germany, 1984).

Sorted by citations

Items 201–300 of 319

Bacteroides uniformis enhances endurance exercise performance through gluconeogenesisPreprint
Morita, H., Kano, C., Ishii, C., Kagata, N., Ishikawa, T., Uchiyama, Y., Hara, S., Nakamura, T., & Fukuda, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.04.975730 · Cited by 6
Metformin improves glycemia independently of skeletal muscle AMPK via enhanced intestinal glucose clearancePreprint
Kjøbsted, R., Kristensen, J. M., Birk, J. B., Eskesen, N. O., Kido, K., Andersen, N. R., Larsen, J. K., Foretz, M., Viollet, B., Nielsen, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.22.492936 · Cited by 6
Self-citation
Comprehensive Review and Perspective on Fructose 1,6-Bisphosphatase Inhibitors for the Management of Type 2 Diabetes Mellitus
Sawant, S. D., & Sawant, V. N. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024605299 · Cited by 6
Effects of Metformin Treatment Against Endometrial Cancer Cells Cultured In Vitro or Grafted into Female Balb/C Nude Mice: Insights into Cell Response and IGF-1R and PI3K/AKT/mTOR Signaling Pathways
dos Reis, V. M. S. F., Ramos, F. M., de Oliveira, H. L., Machado, F. D., Hartke, S., Machado-Weber, A., Germeyer, A., Strowitzki, T., Kliemann, L. M., Corleta, H. V. E., et al. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01840-0 · Cited by 5
PEN2: Metformin’s new partner at lysosome
Sakamoto, K., & Jessen, N. (2022) · Cell Research · doi:10.1038/s41422-022-00661-7 · Cited by 5
Self-citation
Disorders of Fructose Metabolism
Steinmann, B. U., & Santer, R. (2022) · Springer eBooks · doi:10.1007/978-3-662-63123-2_15 · Cited by 5
Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients
Nakatani, E., Ohno, H., Satoh, T., Funaki, D., Ueki, C., Matsunaga, T., Nagahama, T., Tonoike, T., Yui, H., Miyakoshi, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308734 · Cited by 4
Meeting metformin again for the first time
Green, D. R. (2024) · Science Advances · doi:10.1126/sciadv.adu7436 · Cited by 6
Causal association of metformin treatment with diverse immune-mediated inflammatory diseases: A Mendelian randomization analysis
Liao, Z., Su, C., Li, J., & Liu, J. (2025) · Medicine · doi:10.1097/md.0000000000041400 · Cited by 4
Combined deletion of cytosolic 5′-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production
Jacobs, R., Herinckx, G., Galland, N., Balty, C., Vertommen, D., Rider, M. H., & Johanns, M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108295 · Cited by 4
Metformin and its Nanoformulations in Cancer Prevention and Therapy
Banerjee, B., Banerjee, S., Sharma, T., Nandy, B. C., Nayak, A. K., & Mondal, A. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128367242250214052019 · Cited by 4
Entering the Sugar Rush Era: Revisiting the Antihyperglycemic Activities of Biguanides after a Century of Metformin Discovery
Neto, X. A. D. O., Barssotti, L., Fiori-Duarte, A. T., Barbosa, H. C. L., & Kawano, D. F. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220820151959 · Cited by 4
Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome
DiNicolantonio, J. J., McCarty, M. F., & O’Keefe, J. H. (2019) · Open Heart · doi:10.1136/openhrt-2018-000977 · Cited by 4
Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors
Panikar, S. S., Keltee, N., Berry, N.-K., Shmuel, S., Fisher, Z. T., Brown, E. L., Zidel, A., Mabry, A., & Pereira, P. M. R. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.265248 · Cited by 4
Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking
Liu, C., Zhang, S., Xue, J., Zhang, H., & Yin, J. (2023) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2023.111580 · Cited by 4
Functional and Biochemical Analyses of Glycerol Kinase and Glycerol 3-phosphate Dehydrogenase in HEK293 Cells
Syngkli, S., Singh, S. K., Rani, R. M., & Das, B. (2025) · The Protein Journal · doi:10.1007/s10930-025-10252-1 · Cited by 3
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes
Li, H., Zhang, X., Liang, X., Li, S., Cui, Z., Zhao, X., Wang, K., Zha, B., Ma, H., Xu, M., et al. (2025) · eLife · doi:10.7554/elife.103663.3 · Cited by 3
Novel AMP-activated protein kinase activators and their potential for mitigating renal injury and fibrosis
Harley, G., & Mount, P. F. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103741 · Cited by 3
Postprandial glucose profiles may reflect heterogeneity in insulin secretion and sensitivity in type 2 diabetes
Giosuè, A., Skantze, V., Testa, R., D’Abbronzo, G., Costabile, G., Vitale, M., Corrado, A., Jirstrand, M., Landberg, R., Riccardi, G., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156626 · Cited by 8
Challenge of diabetes mellitus and researchers’ contributions to its control
Odularu, A. T., & Ajibade, P. A. (2021) · Open Chemistry · doi:10.1515/chem-2020-0153 · Cited by 3
Données récentes sur le mécanisme d’action de la metformine dans le diabète de type 2
Foretz, M., Guigas, B., & Viollet, B. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.09.005 · Cited by 3
Brain Permeable AMP-Activated Protein Kinase Activator R481 Raises Glycaemia by Autonomic Nervous System Activation and Amplifies the Counterregulatory Response to Hypoglycaemia in Rats
Cruz, A. M., Partridge, K. M., Malekizadeh, Y., Walker, J. M. V., Potter, P. G. W., Pye, K. R., Shaw, S. J., Ellacott, K. L. J., & Beall, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697445 · Cited by 3
Peeling back the layers of the glucose clamp
Ayala, J. E., Lantier, L., McGuinness, O. P., & Wasserman, D. H. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00573-1 · Cited by 3
Self-citation
Identification of phytocompounds as potent inhibitors of sodium/glucose cotransporter-2 leading to diabetes treatment
Swargiary, A., Daimari, M., Swargiary, A., Biswas, A., Brahma, D., & Singha, H. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2319674 · Cited by 3
A New Understanding of Metformin
Hardie, D. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00099-2 · Cited by 3
Metformin: A Leading HDT Candidate for TB
Singhal, A., & Kornfeld, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_7 · Cited by 3
Repurposing drugs for the treatment of galactosemia
Timson, D. J. (2019) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1672533 · Cited by 3
Toward metabolic precision medicine in heart failure: Timing, tissue specificity, and network reconstruction
Chen, L., Yang, X. Y., Jiang, Y., Cheng, S.-Q., Wan, Z., Wu, J.-W., Chen, M., Li, Y., Luo, G., & Liu, M. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124413 · Cited by 2
Can Persistent Children Hyperglycemia Be Induced by Causes Other Than Pancreas Failure?
Assis, A. S. D., & Nobrega, J. L. P. D. (2022) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2022.127011 · Cited by 2
The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan
Harada, M., Kondo, Y., Sugiyama, M., Ohira, A., Ichikawa, M., Akiyama, T., Orime, K., Takai, T., Yamakawa, T., & Terauchi, Y. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0330 · Cited by 3
PLGA-based microspheres loaded with metformin hydrochloride: Modified double emulsion method preparation, optimization, characterization, and in vitro evaluation
Chauhan, P., Paliwal, H., Chauhan, C., & Paliwal, A. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2023.09.002 · Cited by 2
Preoperative Patient Evaluation
Villasenor, M., & Selzer, A. R. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2023.08.004 · Cited by 2
A Review on Affordable Combinations in Type 2 Diabetes Care: Exploring the Cost-Effective Potential of Glipizide + Metformin and Glimepiride + Metformin + Pioglitazone
Shaikh, S. S., Vaidya, V., Gupta, A. K., Kulkarni, R., Joshi, A., Kulkarni, M., Sharma, V., & Revankar, S. Y. (2024) · Cureus · doi:10.7759/cureus.59850 · Cited by 3
Genistein and metformin regulate glycerol kinase and the enzymes of glycerol 3-phosphate shuttle in a differential manner in myocytes, hepatocytes and adipocytes
Syngkli, S., Singh, S. K., Rani, R. M., & Das, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132296 · Cited by 2
NF-kappa B signaling pathway is associated with metformin resistance in type 2 diabetes patients
Mansouri, V., Bandarian, F., Razi, F., Razzaghi, Z., Tavirani, M. R., Rezaei, M. S., Arjmand, B., & Rezaei–Tavirani, M. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01458-8 · Cited by 2
Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models
Patani, K., Joharapurkar, A. A., Sundar, R., Kshirsagar, S. G., Metiya, S., Kumar, A., & Jain, M. R. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.108977 · Cited by 2
Pharmacophysiological insights into the paradoxical increase in endogenous glucose production with metformin treatment
Methnani, J., Ach, T., Hraïech, A. E., Latiri, I., Bouslama, A., Zaouali, M., Omezzine, A., & Bouhlel, E. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117112 · Cited by 2
Nuclear magnetic resonance spectroscopy-based urinalysis for a young girl with extreme hypoglycaemia
Law, C. Y., Kwok, A. M. K., Ling, T.-K., Wong, K. C., Lau, N. K. C., Poon, G. W.-K., & Lam, C. (2021) · Pathology · doi:10.1016/j.pathol.2021.07.013 · Cited by 2
Pioglitazone and Metformin on Improving Cognitive Dysfunction Caused by Diabetes Mellitus: A Comparative Study
Alhowail, A. H., Alomran, A., Alqefari, N., Aldubayan, M. A., & Alenezi, S. K. (2023) · International Journal of Pharmacology · doi:10.3923/ijp.2023.505.513 · Cited by 2
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetesPreprint
Li, H., Zhang, X., Liang, X., Li, S., Cui, Z., Zhao, X., Wang, K., Zha, B., Ma, H., Xu, M., et al. (2024) · eLife · doi:10.7554/elife.103663 · Cited by 2
Systematic Investigation of Dose-Dependent Protein Thermal Stability Changes to Uncover the Mechanisms of the Pleiotropic Effects of Metformin
Yin, K., & Wu, R. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00298 · Cited by 1
Type 2 diabetes and the role of nurses in its management
Butler, S. M. (2025) · Nursing Standard · doi:10.7748/ns.2025.e12429 · Cited by 2
When our treatment is complicated: an overview of drug-induced acid–base disorders: part 1—acidosis
Florio, G., & Böckenhauer, D. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06785-3 · Cited by 1
Unveiling the Antidiabetic Potential of 6-Chloro-3-(2-substituted-4-oxothiazolidin-3-yl)-2-phenylquinazolin-4(3H)-one Derivatives: Design, Synthesis, and Biological Evaluation Targeting Fructose 1,6-Bisphosphatase with In Silico ADMET and Docking Approaches
Sawant, S. D., & Sawant, V. N. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162025600047 · Cited by 1
Cardiovascular Disease and Diabetes: A New Challenge in the Treatment and Management
Riccioni, G., Notarangelo, C., Riccioni, M., & D’Orazio, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010354 · Cited by 1
Improving erectile function in diabetic male mice by rescuing depalmitoylated FBP1 to reduce cavernosal lactate
My, X., Guo, W., Zeng, R., Wu, S., & Jin, X. (2026) · Nature Communications · doi:10.1038/s41467-026-68443-y · Cited by 1
Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease
Khan, S. A., Raza, K., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1676065 · Cited by 1
Metformin—A Type 2 Diabetes Mellitus Drug—And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications
Sielski, E., Noumani, S. A., Bower, E., Cunningham, K., Beidel, G., Luchianova, A., Courreges, M. C., & Benencia, F. (2026) · Biomolecules · doi:10.3390/biom16030413 · Cited by 1
Metformin-associated lactic acidosis: Bridging pharmacokinetic determinants, metabolic pathways, and clinical outcomes
Anwar, K. R., Khan, M. M., Badruddeen, B., Nisha, A., Siddiqui, E. M., & Ahmad, U. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179017 · Cited by 2
Biphasic Responses of Porcine Oocytes to Metformin: Concentration-Dependent AMPK Activation and Nrf2-Mediated Antioxidant Regulation
Wang, J., Li, M. Y., Zhou, Y., Fu, F., Liu, F., Tan, J., Luo, M., & Gong, S. (2026) · Animals · doi:10.3390/ani16121828 · Cited by 1
Design, synthesis and structure activity relationship of fructose-1, 6 bisphosphatase inhibitors
Sawant, S., Sawant, V. N., Avhad, P., & More, M. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00827-x · Cited by 1
Metformin and sitagliptin fixed combination as the optimal choice in solving current problems in the type 2 diabetes mellitus treatment
Biryukova, E. V., & Kileynikov, D. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-156 · Cited by 1
Combined Administration of Metformin and Vitamin D: A Futuristic Approach for Management of Hyperglycemia
Tyagi, S., & Mani, S. (2023) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257261643231018102928 · Cited by 1
A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep
Kumawat, B. L., Kumar, P., Mahla, A. S., Kumar, A., Kumar, A., Singh, R., & Kumar, A. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10259-y · Cited by 1
Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity
Qiao, A., Ma, W., Jiang, Y., Han, C., Yan, B., Zhou, J., & Qin, G. (2022) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamol4ed.4.23.9 · Cited by 1
Elucidating metformin action on the ovary and fertility in healthy mice
Velázquez, C., Bordaquievich, M., Herrero, Y., Cohen, D. J., Bianchi, M. S., Cuasnicu, P. S., Prost, K., Pascuali, N., Parborell, F., & Abramovich, D. (2024) · Reproduction · doi:10.1530/rep-24-0229 · Cited by 1
Antidiabetic Potential of Plants Used in Bulgarian Folk Medicine and Traditional Diet
Nashar, M. A., Kiselova-Kaneva, Y. D., & Ivanova, D. G. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85445 · Cited by 1
AMP-Activated Protein Kinase
Hardie, D. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_177-1 · Cited by 1
Network analysis to trace the common key gene (s) involved in antihyperglycemic effects mediated through co-supplementation of Vitamin D and MetforminPreprint
Tyagi, S., & Mani, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3539016/v1 · Cited by 1
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetesPreprint
Li, H., Zhang, X., Liang, X., Li, S., Cui, Z., Zhao, X., Wang, K., Zha, B., Ma, H., Xu, M., et al. (2025) · eLife · doi:10.7554/elife.103663.2 · Cited by 1
Metformin use in polycystic ovary syndrome pregnancy impacts on offspring obesity
Abbott, D. H. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30001-x
Mechanisms By Which Glucose Lowering Therapies Reduce Obesity And Atherosclerosis
Day, E. A. (2020) · MacSphere (McMaster University) · doi:10.71548/25269
Metformin: an old drug with potential therapeutic function in antitumorPreprint
Mu, W., Jiang, Y., & Qu, F. (2021) · doi:10.22541/au.163640852.26812577/v1
AMP-Activated Protein Kinase
Hardie, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_177
Alleviation of Liver Fibrosis Via Hepatic Stellate Cells Mitochondrial Apoptosis Induced by MetforminPreprint
Su, Y., Lu, S., Ren, K., Wang, M., Hou, C., Liu, X., Zhao, S., & Liu, X. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3990740
Murine double minute gene 2 (MDM2) promoted hepatocellular carcinoma (HCC) cell growth by targeting fructose-1,6-bisphosphatase (FBP1) for degradation
Xu, Y. Q., Wu, B., Yang, J., ZHANG, S., Liu, L., Suobao, X., & JIANG, J. (2022) · Biocell · doi:10.32604/biocell.2022.017745
Low glucose metabolizing capacity and not insulin resistance is primary etiology of type 2 Diabetes Mellitus: A hypothesis
Saikia, D., & Kumar, S. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110804
Oxidative stress and metformin: An in-vitro study on serum and primary human granulosa cell cultures
Rehman, R., Alam, F., Abidi, S. H., Farooqi, N., & Jehan, F. (2022) · Electronic Journal of General Medicine · doi:10.29333/ejgm/12037
Inborn errors of fructose metabolism
Cox, T. M. (2020) · doi:10.1093/med/9780198746690.003.0228
AMPK deficiency in smooth muscles causes persistent pulmonary hypertension after birth and premature deathPreprint
Moral‐Sanz, J., Lewis, S. A., MacMillan, S., Meloni, M., McClafferty, H., Viollet, B., Foretz, M., Del‐Pozo, J., & Evans, A. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495329
Evre 4 ve 5 Kronik Böbrek Hastaları Metformin Kullanmamalı mı?
Çiftçioğlu, M. (2022) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1181458
The Effectiveness of Black Garlic (Allium sativum L. Fermentation) on Blood Glucose Levels in Streptozotocin-Induced Diabetic Rats
Kamila, S. R., Mukono, I. S., & Indiastuti, D. N. (2023) · International Journal of Research Publications · doi:10.47119/ijrp1001171120234449
FBP1 is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsivenessPreprint
Gu, L., Zhu, Y., Watari, K., Lee, M., Liu, J., Perez, S., Thai, M., Mayfield, J. E., Zhang, B., Rocha, K. C. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.05.531181
Data from A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis
Liao, K., Deng, S., Xu, L., Pan, W., Yang, S., Zheng, F., Wu, X., Hu, H., Liu, Z., Luo, J., et al. (2023) · doi:10.1158/0008-5472.c.6511995.v1
Data from A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis
Liao, K., Deng, S., Xu, L., Pan, W., Yang, S., Zheng, F., Wu, X., Hu, H., Liu, Z., Luo, J., et al. (2023) · doi:10.1158/0008-5472.c.6511995
Potential Role of Metformin in Central Nervous System with a Focus on Its Mechanism of Actions
Bora, K., & James, R. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i04.4279 · Cited by 1
The Causal Role of Metformin in Immune Cells Activation: A Mendelian Randomization StudyPreprint
Chen, P., Zheng, H., Ni, S., & Ouyang, L. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4631480
Type 2 diabetes mellitus: Novel targets and multitarget-directed phytotherapy
Chhipa, A. S., Verma, S., & Patel, S. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95719-9.00008-2 · Cited by 1
ADVANTAGES OF METFORMIN FOR A DIVERSITY OF DISEASES
Jaiswal, H., Panda, P. D., & Bharatia, R. (2023) · International Journal of Pharma Professional’s Research (IJPPR) · doi:10.48165/ijppronline.2023.14106
AMPK activation promotes transcriptional activation of TFEB through its dephosphorylationPreprint
Negoita, F., Bringas, C. F., Hellberg, K., Luda, K. M., Liu, H., Cuenco, J., Zhao, J., Sathe, G. J., Sapkota, G. P., & Sakamoto, K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.619589
Self-citation
TET2 contributes to gluconeogenesis and pathology of type 2 diabetesPreprint
Zhang, X., Li, H., Li, S., Cui, Z., Zhao, X., Lv, L., Xu, M., & Xu, Y. (2024) · eLife · doi:10.2139/ssrn.4913726
Repurposing metformin: A potential off‐label indication for ischaemic stroke?
Oo, T. T. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16105
Heightened sensitivity to adverse effects of metformin in mtDNA mutant patient cells
Ryytty, S., Nurminen, K., Mäkinen, P. I., Suomalainen, A., & Hämäläinen, R. H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123486
The Ancient Drug Salicylate Indirectly Targets Fructose‐1,6‐Bisphosphatase to Suppress Liver Glucose Production in Diet‐Induced Obese Mice
Nisr, R. B., Atrih, A., Lara, E. J. G., Lamont, D. J., Luda, K. M., McCrimmon, R. J., Sakamoto, K., Rena, G., & McNeilly, A. D. (2025) · Acta Physiologica · doi:10.1111/apha.70058
Self-citation
Therapeutic effects of Scutellaria baicalensis total flavonoids on metabolic syndrome in rats via modulation of PPARα and PPARγ signaling
Zhou, Y., Li, Z., Lian, Y.-H., Gao, X., Yin, S., & Zhao, Y. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10606-0
Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations
Valencia, M. L., Aponte, R. A. V., Baur, J. A., Jongens, T. A., & Sehgal, A. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf149
Impact des traits d’histoire de vie du microcèbe (Microcebus murinus) dans la régulation du métabolisme en réponse à l’environnement
Terrien, J. (2025) · Revue de primatologie · doi:10.4000/14ycc · Cited by 1
Additional file 3 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648916
Additional file 12 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648943
Additional file 9 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648934
Additional file 5 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648922
Additional file 14 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648949
Additional file 8 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648931
Additional file 11 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648940
Additional file 13 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648946
Additional file 4 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648919
Additional file 2 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648913
Additional file 7 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648928
Additional file 6 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648925
Additional file 10 of Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2024) · Figshare · doi:10.6084/m9.figshare.26648937

Authors: Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K.
Affiliations: University of Bristol (GB)
Vanderbilt University (US)
Aarhus University (DK)
University of Dundee (GB)
Mount Sinai Hospital (CA)
Corresponding author: Sakamoto, Kei
ORCID: Hunter, Roger W.
Hughey, Curtis C.
Lantier, Louise
Sundelin, Elias I.
Peggie, Mark
Zeqiraj, Elton
Sicheri, Frank
Jessen, Niels
Wasserman, David H.
Sakamoto, Kei
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2018-08-27
Volume: 24
Issue: 9
Pages: 1395-1406
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/s41591-018-0159-7
PMC: PMC6207338
OpenAlex: W2888330909
Cited by: 313
References: 86
Citations by year: 2026: 25 · 2025: 33 · 2024: 47 · 2023: 53 · 2022: 49 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 4
FWCI: 9.51
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
Explore Bristol Research (publishedVersion, other-oa)
White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Bristol Research (University of Bristol) (submittedVersion, other-oa)
Funders: Vanderbilt University (DK059637)
Wellcome Trust (092381)
Novo Nordisk
Danmarks Frie Forskningsfond (4183-00384)
Novo Nordisk Fonden (NNF13OC0003882, NNF17SA0031230-1)
Canadian Institutes of Health Research (143277)
National Institute of Diabetes and Digestive and Kidney Diseases (U2CDK059637, U24DK059637, R37DK050277, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords: metformin, FBP1, hepatic glucose production, gluconeogenesis, AMPK, fructose-2,6-bisphosphate, type 2 diabetes, high-fat diet, euglycemic clamp
MeSH terms: Adenosine Monophosphate, Aminoimidazole Carboxamide, Animals, Base Sequence, Chickens, Disease Models, Animal, Glucose, Fructose-Bisphosphatase, Homeostasis, Humans, Hypoglycemia, Liver, Metformin, Mice, Inbred C57BL, Mutation, Obesity, Prodrugs, Ribonucleotides, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks